Vitiligo: advances in pathophysiology research and treatment development
- 4 May 2024
- journal article
- research article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 30 (9) , 844-862
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and Higher Education of the Republic of Kazakhstan (AP13068072)
- LEO Foundation (LF-OC-23-001288)
This publication has 94 references indexed in Scilit:
- A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory MonitoringDermatology and Therapy, 2023
- Psychosocial Effects of Vitiligo: A Systematic Literature ReviewAmerican Journal of Clinical Dermatology, 2021
- The Role of Diet and Supplements in Vitiligo ManagementDermatologic Clinics, 2017
- CD49a Expression Defines Tissue-Resident CD8 + T Cells Poised for Cytotoxic Function in Human SkinImmunity, 2017
- Phototherapy: The vitiligo management pillarClinics in Dermatology, 2016
- Portable home phototherapy for vitiligoClinics in Dermatology, 2016
- A Double-blind Randomized Trial of 0.1% Tacrolimus vs 0.05% Clobetasol for the Treatment of Childhood VitiligoArchives of Dermatology, 2003
- Increased Pigmentation of Iridial Melanocytes in Primates Induced by a Prostaglandin AnalogueExperimental Eye Research, 1999
- The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 ADJournal of Photochemistry and Photobiology B: Biology, 1992
- PUVA and skin cancerJournal of the American Academy of Dermatology, 1992